Home
Company
History
Management
Board of Directors
How to find us
Strategy
Pipeline
Partnering
PENTRA® Technology
PENTRA® Antibody Fragments
Background
Intellectual Property
Glossary
Investors
Media
News
Presentations
Publications
Conferences
Contact
|
Career
|
Disclaimer
|
Print
select
German
French
Italian
Management
Dr. Eric de La Fortelle
Chief Executive Officer
Dr. Thomas Jung
Chief Medical Officer
Dr. Titus Kretzschmar
Chief Scientific Officer
Jakob Schlapbach
Chief Financial Officer
© 2012
Delenex Therapeutics AG | Wagistrasse 27 | CH-8952 Schlieren/Zürich | Switzerland